Summary of Judgment

1. Introduction

This judgment concerns a delictual damages action instituted against the Road Accident Fund (“the Fund”) arising from bodily injuries sustained in a motor vehicle collision. The Plaintiff, Bheki Maurice Cele, sued the Fund for compensation flowing from an accident that occurred on or about 16 July 2017 near R[...] E[...] Road, Nelspruit, Mpumalanga Province, when two vehicles collided.

The matter came before the High Court of South Africa, Mpumalanga Division, Mbombela Main Seat, as a trial action in which the Defendant delivered a plea that included two special pleas. By agreement at the hearing, the court was requested to determine the special pleas first, and in particular to deal only with the special plea of prescription.

The dispute, as narrowed for determination, therefore concerned whether the Plaintiff’s claim had become prescribed under the time-bar provisions of the Road Accident Fund Act because summons was issued (and served) more than five years after the accident date, and whether the Fund’s prior role in “representing” the Plaintiff within its internal claims system affected that outcome.

2. Material Facts

The court decided the prescription special plea without oral evidence, relying on the parties’ submissions and what was either common cause or not placed in dispute.

It was common cause (or treated as effectively undisputed on the papers and submissions) that the collision giving rise to the Plaintiff’s cause of action occurred on or about 16 July 2017.

It was further accepted in argument that the Plaintiff lodged a claim directly with the Fund shortly after the accident. The judgment records inconsistent dates in the Plaintiff’s heads of argument, but the Fund’s version (also recorded by the court) was that the Plaintiff lodged a direct claim with the Fund on 21 July 2017.

A further fact the court treated as undisputed was that, through its internal claims system, the Fund had assumed a role described as acting as the Plaintiff’s legal representative prior to the appointment of the Plaintiff’s current attorneys. The Fund did not dispute that it assumed this role, nor did it dispute that it did not process the claim to finality before prescription became an issue.

The Plaintiff terminated the Fund’s mandate on or about 24 January 2022, after which the Plaintiff instructed Nkhwashu-Magaggula Attorneys. The termination and substitution were followed by service of the termination of mandate and notice of appointment as attorneys of record, recorded as having occurred on or about 25 January 2022.

Summons was issued on 31 January 2024 and served on the Fund on 24 February 2024.

The Fund’s special plea alleged that the Plaintiff was required by section 23(3) of the Road Accident Fund Act to issue and file summons within five years from the date the cause of action arose, that the five-year period expired on 15 July 2022, and that summons issued on 31 January 2024 was therefore out of time.

The Plaintiff’s replication asserted, in substance, that the Plaintiff had lodged the claim without external legal advice, that the Fund acted on the Plaintiff’s behalf, that the Plaintiff could not reasonably have been expected to issue summons while “represented” by the Fund, and that the Fund could not issue summons against itself. The replication relied on the termination of mandate and subsequent appointment of attorneys as the point from which the Plaintiff could reasonably be expected to take steps.

3. Legal Issues

The central legal question was whether the Plaintiff’s claim had prescribed under the five-year time bar applicable to Road Accident Fund claims, given the date of the accident and the date of issue (and service) of summons.

A related legal issue was whether section 12(3) of the Prescription Act, which deals generally with when prescription begins to run, had any application in Road Accident Fund matters, or whether prescription is regulated exclusively by the Road Accident Fund Act.

The case further presented a question of application of law to fact combined with an evaluative assessment. Even accepting that the statutory five-year period ran from the accident date, the court had to determine whether, on the facts it accepted as undisputed, it was fair and legally acceptable for the Fund to rely on prescription where the Fund had acted as the Plaintiff’s internal “legal representative” and failed to process the claim for most of the five-year period.

The dispute thus involved legal interpretation (the governing prescription regime), application (how the regime applied on the accepted timeline), and an evaluative judgment (whether the Fund should be permitted to benefit from the consequences of its own inaction in circumstances where it had assumed a representative role).

4. Court’s Reasoning

The court began by addressing the Prescription Act argument. It held that section 12(3) of the Prescription Act is not applicable to Road Accident Fund matters, accepting the Fund’s contention on this point as correct in light of Constitutional Court authority drawing a distinction between the Prescription Act and the Road Accident Fund Act. The court therefore rejected any approach that would import the Prescription Act’s general rules into the specific statutory scheme governing Road Accident Fund prescription.

However, the court treated this conclusion as not dispositive of the special plea. It noted that no evidence was led, and it distilled from the submissions a set of propositions it treated as effectively undisputed: the Fund had assumed the Plaintiff’s legal representation before the Plaintiff’s current attorneys came on record; the Fund did not process the claim until it prescribed (or until prescription became an issue); and the Plaintiff terminated the Fund’s mandate because of the Fund’s failure to process the claim.

On that factual footing, the court reasoned that, because the Fund acted as the Plaintiff’s legal representative through its internal claims system, the Fund bore a duty to ensure the claim was properly dealt with. It found, as a matter of evaluation, that the Fund did not handle the Plaintiff’s matter with the required care.

The court then engaged the Fund’s main contention on the timeline. It accepted that, on the Fund’s version, the Fund’s mandate was terminated about five months before the five-year period expired, and that the Plaintiff’s attorneys therefore had that remaining period within which to issue summons. The court acknowledged that this argument might appear persuasive “at face value”.

Nevertheless, the court concluded that the Fund should not be allowed to benefit from the consequence of its own prior inaction, drawing support from authorities relied upon by the Plaintiff that emphasise a heightened duty of care when the Fund is dealing with unrepresented claimants and should not profit from its neglect. The court distinguished those cases on the basis that they dealt with situations where prescription had already taken effect, whereas here the mandate was terminated before prescription would have operated. This led the court to formulate the specific question in this matter as whether the Plaintiff’s newly-appointed attorneys should be blamed for not issuing summons within the remaining five-month period.

The court answered that question in the negative. It reasoned that the Plaintiff should have the full benefit of the five-year statutory period afforded by the Road Accident Fund Act, and that in this instance the Fund had effectively wasted four years and seven months, without offering an explanation. In the court’s evaluation, it would be unfair to expect the Plaintiff and the newly-appointed attorneys to prepare and issue summons “hastily” within a truncated remaining period when the statutory scheme contemplated a full five-year window, particularly where the shortening of the available time was attributable to the Fund’s own failure to process the claim while it purported to act on the Plaintiff’s behalf.

On that basis, the court held that the special plea of prescription could not succeed, and it dismissed the plea.

5. Outcome and Relief

The court held that the Plaintiff’s claim had not prescribed and dismissed the Defendant’s special plea on prescription.

The court ordered the Defendant to pay the Plaintiff’s costs on the High Court Scale C.

Cases Cited

Lottering v RAF and Another 2021 ZANCHC 36 (13 August 2021)

Ralph v The Road Accident Fund 2014/03112 [2016] ZAGPJHC 94

Road Accident Fund v Mdeyide (CCT/10/10) [2010] ZACC 18; 2011 (1) BCLR 1 (CC); 2011 (2) SA 26 (CC) (30 September 2010)

Van Zyl NO v Road Accident Fund (full citation not provided in the judgment text)

Legislation Cited

Road Accident Fund Act 56 of 1996, section 23(3)

Prescription Act, section 12(3)

Rules of Court Cited

No rules of court were cited in the judgment.

Held

The court found that section 12(3) of the Prescription Act does not apply to Road Accident Fund matters, which are governed by the prescription provisions in the Road Accident Fund Act. Despite the accident having occurred more than five years before summons was issued, the court concluded that the Fund had, through its internal system, assumed the role of the Plaintiff’s legal representative and failed to process the claim for the bulk of the statutory period. The court held that it would be unfair for the Fund to rely on prescription in circumstances where its own inaction effectively deprived the Plaintiff of the full benefit of the statutory period. The Defendant’s special plea of prescription was therefore dismissed, with costs awarded to the Plaintiff on High Court Scale C.

LEGAL PRINCIPLES

The judgment applied the principle that prescription for Road Accident Fund claims is governed by the Road Accident Fund Act, and that the general prescription provisions in the Prescription Act, including section 12(3), are not applicable in that statutory context.

The judgment further applied the principle, drawn from the authorities relied upon, that where the Fund engages directly with claimants and assumes a representative or guiding role in the processing and settlement of claims, a heightened duty of care rests on the Fund to take reasonable steps to prevent prejudice to the claimant, including prejudice arising from prescription.

In applying those principles, the court endorsed an evaluative norm that the Fund should not be permitted to benefit from its own inaction where the Fund’s failure to process the claim within the statutory period contributed materially to the claimant’s position, and where reliance on prescription would operate unfairly in the circumstances accepted by the court.